Skip to content
★ Sign in to follow
JA

Jason Adams

CFO
Rennova Health, Inc.
Total declarations
4
Company
1
▲ Purchases (3 ops.)
€636
▼ Sales (0 ops.)
—

Latest filing published 27 Jul 2016 for Rennova Health, Inc..

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Jason Adams: trading record in brief

Jason Adams appears in our data through filings on Rennova Health, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 3 June 2016 to 17 July 2016.

Purchases make up the whole of the open-market record (3 purchases, €636). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.

Half of the purchases are above €177 and half below.

The newest entry dates from 27 July 2016: a share grant, in Rennova Health, Inc. The last purchase on record was published on 15 July 2016, which is 3,769 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jason Adams

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    Chief Financial OfficerExecutivesRennova Health, Inc.
    0SEC
    166,667 shares0Common StockSEC:0001548700-16-000004:0
  • ▲
    Chief Financial OfficerExecutivesRennova Health, Inc.
    325 USD39SEC
    1,160 shares@ US$0.2801100.0% of flowCommon StockSEC:0001548700-16-000003:0
    Canonical exit: 12 Oct 2016 (T+90)
  • ▲
    Chief Financial OfficerExecutivesRennova Health, Inc.
    201 USD0SEC
    270 shares@ US$0.745Common StockSEC:0001019687-16-006634:0
    Canonical exit: 5 Sept 2016 (T+90)
  • ▲
    Chief Financial OfficerExecutivesRennova Health, Inc.
    186 USD0SEC
    295 shares@ US$0.63Common StockSEC:0001019687-16-006574:0
    Canonical exit: 1 Sept 2016 (T+90)

4 of 4 declarations